Announced
Completed
Synopsis
OpenAI Startup Fund, a venture investment vehicle supporting AI-driven startups, led a $30m Seed round in Valthos, a biotechnology startup developing AI-driven biodefense systems, with participation from Lux Capital and Founders Fund. "The issue at the core of biodefense is asymmetry. It's easier to make a pathogen than a cure. We're building tools to help experts at the frontlines of biodefense move as fast as the threats they face," Kathleen McMahon, Valthos co-founder.
Principals
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
Claim DealAll rights reserved. Copyright © 2026 Datasite
Seller Team (2)
Bidder Team (1)
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy